Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q1 2024 · 10-Q
Revenue$2.15B$2.15B+10.8% vs Q1 2023 Net Income-$64.00M-$64.00MN/M vs Q1 2023 EPS Diluted-$0.17-$0.17N/M vs Q1 2023 Operating Income$281,000,000+60.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived$129,000,000+20.6% Margins · derivedOperating margin13.1%+4.0 pt vs Q1 2023
Net margin-3.0%+7.4 pt vs Q1 2023
ended Mar 31, 2024 · filed May 2, 2024 · 32 d after period end